HCV and Lymphoproliferation

HCV and Lymphoproliferation

Hepatitis C virus (HCV) infection is a serious public health problem because of its worldwide diffusion and sequelae. It is not only a hepatotropic but also a lymphotropic agent and is responsible not only for liver injury—potentially evolving to cirrhosis and hepatocellular carcinoma—but also for a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Anna Linda Zignego, Carlo Giannini, Laura Gragnani
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2012/980942
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations
by: S. Eldershaw, et al.
Published: (2025-02-01)

Lymphoproliferation and hyper-IgM as the first manifestation of activated phosphoinositide 3-kinase δ syndrome: A case report
by: Mónica Fernandes-Pineda, et al.
Published: (2024-12-01)

Combined Treatment with Antiviral Therapy and Rituximab in Patients with Mixed Cryoglobulinemia: Review of the Literature and Report of a Case Using Direct Antiviral Agents-Based Antihepatitis C Virus Therapy
by: Teresa Urraro, et al.
Published: (2015-01-01)

Virological Mechanisms in the Coinfection between HIV and HCV
by: Maria Carla Liberto, et al.
Published: (2015-01-01)

Cytokines and HCV-Related Disorders
by: Poupak Fallahi, et al.
Published: (2012-01-01)

TLRs, Alcohol, HCV, and Tumorigenesis
by: Keigo Machida
Published: (2010-01-01)

HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role
by: Giuseppe Sautto, et al.
Published: (2012-01-01)

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients
by: Ana Virseda-Berdices, et al.
Published: (2025-01-01)

Optimizing Hepatitis C Therapy in HIV/hepatitis C Virus (HCV) Coinfected Patients: Analysis of HCV Viral Kinetics on Treatment
by: Paul Damien James, et al.
Published: (2012-01-01)

Early Changes in Hepatitis C Virus (HCV) RNA Levels Predict Response to Interferon Treatment in Non-Cirrhotic HCV Patients
by: Glen Fallows, et al.
Published: (2000-01-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Orbital Pseudotumor as an Extrahepatic Complication of Chronic HCV Infection
by: Owen Huang, et al.
Published: (2018-01-01)

Enterococcus gallinarum Spontaneous Bacterial Peritonitis in an HCV Cirrhotic
by: Hussein Abidali, et al.
Published: (2015-01-01)

Treatment of HCV infection in patients with steatotic liver disease
by: Robert Flisiak, et al.
Published: (2024-07-01)

Diagnostics, management and treatment of HCV-infection (Part 1)
by: article Editorial
Published: (2010-02-01)

Diagnostics, management and treatment of HCV-infection (Part 2)
by: article Editorial
Published: (2010-04-01)

Immune-Related Disorders and Extrahepatic Diseases in Chronic HCV Infection
by: Domenico Sansonno
Published: (2012-01-01)

Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis
by: Nikolaos P. Karidis, et al.
Published: (2015-01-01)

Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection
by: Michele Barone, et al.
Published: (2015-01-01)

Transmission of HIV and HCV within Former Soviet Union Countries
by: Lazzat Aibekova, et al.
Published: (2020-01-01)

Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01)

Geographic Distribution of HCV Genotypes and Efficacy of Direct-Acting Antivirals in Chronic HCV-Infected Patients in North and Northeast China: A Real-World Multicenter Study
by: Wencong Li, et al.
Published: (2022-01-01)

Effectiveness of glecaprevir/pibrentasvir in HIV/HCV-coinfected patients treated with bictegravir/emtricitabine/tenofovir alafenamide
by: Aleksandra Berkan-Kawińska, et al.
Published: (2024-07-01)

Observational pilot using a Data to Care intervention strategy to promote HCV re-engagement and cure for persons with HIV/HCV co-infection who are out of care
by: Maximilian Wegener, et al.
Published: (2025-01-01)

HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients
by: Matheus Truccolo Michalczuk, et al.
Published: (2012-01-01)

Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins
by: E. A. Antropova, et al.
Published: (2023-01-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Modelling the potential clinical and economic impact of universal antenatal hepatitis C (HCV) screening and providing treatment for pregnant women with HCV and their infants in Egypt: a cost-effectiveness study
by: Giuseppe Indolfi, et al.
Published: (2024-04-01)

Incidence of Severe Hepatotoxicity Related to Antiretroviral Therapy in HIV/HCV Coinfected Patients
by: Emily L. Heil, et al.
Published: (2010-01-01)

Corrigendum to “Extraction of HCV-RNA from Plasma Samples: Development towards Semiautomation”
by: Imran Amin, et al.
Published: (2016-01-01)

Impact of interferon-free regimens in patients with chronic HCV and successfully ablated HCC
by: Amr Maged Mahmoud Rasheed, et al.
Published: (2025-02-01)

HCV and HIV co-infection among people who inject drugs in Vietnam
by: Vu Toan THINH, et al.
Published: (2020-12-01)

Genotyping of HCV RNA Reveals That 3a Is the Most Prevalent Genotype in Mardan, Pakistan
by: Sajid Ali, et al.
Published: (2014-01-01)

Lack of Disease Specificity Limits the Usefulness of In Vitro Costimulation in HIV- and HCV-Infected Patients
by: Stefanie Kuerten, et al.
Published: (2008-01-01)

Towards an HCV vaccine: an overview of the immunization strategies for eliciting an effective B-cell response
by: Gabriel L. Costa, et al.
Published: (2025-12-01)

Dysregulation in the microbiota by HBV and HCV infection induces an altered cytokine profile in the pathobiome of infection
by: Marcos Daniel Mendes Padilha, et al.
Published: (2025-01-01)

Bridging the gap: advancing health equity and eliminating HBV and HCV among marginalized populations
by: Loreta A. Kondili, et al.
Published: (2025-02-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

New Tools in HCV Diagnosis, in Light of the Enhanced Awareness and the New Drugs for Treatment: SMARTube and Stimmunology
by: Svetlana Gorodin, et al.
Published: (2013-01-01)

Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) in HCV-Positive Egyptian Patients Treated with Sofosbuvir
by: Ali Nada, et al.
Published: (2020-01-01)